Cargando…

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals

OBJECTIVE: Depression has been associated with hepatitis C, as well as with its treatment with proinflammatory cytokines (i.e., interferon). The new direct-acting antiviral agents (DAAs) have minimal adverse effects and high potency, with a direct inhibitory effect on non-structural viral proteins....

Descripción completa

Detalles Bibliográficos
Autores principales:	Egmond, Elfi, Mariño, Zoe, Navines, Ricard, Oriolo, Giovanni, Pla, Anna, Bartres, Concepció, Lens, Sabela, Forns, Xavier, Martin-Santos, Rocio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986477/ https://www.ncbi.nlm.nih.gov/pubmed/31314868 http://dx.doi.org/10.1590/1516-4446-2018-0336

Ejemplares similares

Early changes in brain structure, functional connectivity and neuropsychiatric symptoms after HCV infection cure with direct-acting antivirals
por: Cavero, M., et al.
Publicado: (2021)

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2016)

Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2017)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
por: Navinés, Ricard, et al.
Publicado: (2022)

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy
por: Perpiñán, Elena, et al.
Publicado: (2020)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

Significant early and long-term improvement of neuropsychiatry symptomatology in HCV-infected patients after viral eradication with DAA
por: Martin-Santos, R., et al.
Publicado: (2022)

Less basal thyrotropin levels predict antidepressant response in patients with major depression
por: Navinés, R., et al.
Publicado: (2022)

Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
por: Carver, Alicia B, et al.
Publicado: (2020)

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
por: García-López, Mireia, et al.
Publicado: (2021)

Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
por: Udina, M, et al.
Publicado: (2015)

Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
por: Forns, Xavier, et al.
Publicado: (2021)

Estrés laboral y burnout en los médicos residentes, antes y durante la pandemia por COVID-19: una puesta al día
por: Navinés, Ricard, et al.
Publicado: (2021)

Work stress and resident burnout, before and during the COVID-19 pandemia: An up-date()
por: Navinés, Ricard, et al.
Publicado: (2021)

Curative Effects for B-Cell Lymphoma Accomplished by Direct-Acting Antiviral Agents of Hepatitis C
por: Hattori, Nobuhiro, et al.
Publicado: (2017)

Coste y efectividad de los nuevos antivirales para la hepatitis C.
por: Lens, Sabela, et al.
Publicado: (2015)

Concomitant Treatment of Chronic Hepatitis C With Direct-Acting Antivirals and Multidrug-Resistant Tuberculosis Is Effective and Safe
por: Melikyan, Nara, et al.
Publicado: (2021)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
por: Goutzamanis, Stelliana, et al.
Publicado: (2021)

Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C
por: Gallach, Marta, et al.
Publicado: (2018)

Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review
por: Whelchel, Kristen, et al.
Publicado: (2021)

Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
por: Martinez, Anthony, et al.
Publicado: (2023)

Correction: Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C
por: Gallach, Marta, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct‐Acting Antiviral Treatment Failure in Patients With Hepatitis C?
por: Piecha, Felix, et al.
Publicado: (2019)

Screnning of viral hepatitis in mental disorder patients: Psiqui-Clinic Programme
por: Cavero, M., et al.
Publicado: (2022)

Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents
por: Norton, Brianna L, et al.
Publicado: (2020)

Concomitant Treatment of Hepatitis C Virus and Diffuse Large B-Cell Lymphoma with Direct-Acting Antivirals in HIV Coinfection: A Case Report
por: Gallipani, Alyssa, et al.
Publicado: (2019)

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection
por: Boesecke, Christoph, et al.
Publicado: (2017)

Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort Study
por: Kaul, Christina M, et al.
Publicado: (2023)

Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs?
por: Berzal-Herranz, Alfredo, et al.
Publicado: (2020)

Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
por: Salazar-Vizcaya, Luisa, et al.
Publicado: (2018)

Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function
por: Orr, Cody, et al.
Publicado: (2021)

Three cases of incident lichen planus after direct-acting antiviral treatment for hepatitis C
por: Steuer, Meredith, et al.
Publicado: (2018)

Benign mixed Müllerian (duct) vaginal tumor in a 12-y-old goat
por: Hartung, Svenja, et al.
Publicado: (2022)

Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
por: Rolland, Benjamin, et al.
Publicado: (2022)

An Enabling Act
por: Chalkias, Spyridon, et al.
Publicado: (2014)

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020
por: Busse, Clara E., et al.
Publicado: (2023)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
por: Leal, Cassia, et al.
Publicado: (2023)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient
por: Pla, Jordi Juanola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0hk2s32eldj4bl3mv9lrq86l9q